Alternatives to Nuedexta If You Can't Fill Your Prescription

Nuedexta (dextromethorphan / quinidine sulfate) is the only FDA-approved medication for pseudobulbar affect (PBA). But if you can't get it filled — due to availability, cost, insurance denial, or side effects — your doctor has other tools. This guide explains the most commonly used alternatives and what you should discuss with your neurologist or prescriber.

Why Would Someone Need an Alternative to Nuedexta?

Several common scenarios lead patients to explore alternatives:

Insurance denied the prior authorization and the appeal is pending

The out-of-pocket cost is unmanageable even with discount programs

Nuedexta is contraindicated due to QT prolongation, heart failure, or MAOI use

Nuedexta is unavailable at local pharmacies and the patient needs treatment now

Intolerable side effects such as severe dizziness or diarrhea

Option 1: Tricyclic Antidepressants (TCAs) — Off-Label

Before Nuedexta was approved in 2010, tricyclic antidepressants (TCAs) were the most established pharmacological treatment for PBA. They are not FDA-approved for PBA, but they have been used off-label with clinical evidence supporting their effectiveness — often at lower doses than used for depression.

Commonly used TCAs for PBA include:

Amitriptyline (Elavil): One of the most studied options for PBA. Generic, inexpensive, but has notable anticholinergic side effects (dry mouth, constipation, urinary retention, sedation).

Nortriptyline (Pamelor): Similar to amitriptyline but generally better tolerated with fewer anticholinergic effects. Preferred for older adults.

TCAs are inexpensive — generic amitriptyline can cost as little as $10–$20 per month — but the side effect burden, particularly in older patients and those with cardiac conditions, limits their use.

Option 2: SSRIs — Off-Label

Selective serotonin reuptake inhibitors (SSRIs) are another common off-label option for PBA. They have a more favorable side effect profile than TCAs, making them a first-choice alternative for many prescribers. Research has shown several SSRIs to be effective for reducing PBA episodes:

Fluoxetine (Prozac): 20 mg/day shown effective in clinical trials for PBA. Generic, widely available.

Citalopram (Celexa): 10–30 mg/day used off-label for PBA. Well-tolerated in elderly patients.

Sertraline (Zoloft): 50 mg/day shown effective in small studies. Generic, low cost.

Important note: SSRIs interact with Nuedexta. If you are transitioning between Nuedexta and an SSRI, discuss the timing carefully with your prescriber, as dextromethorphan (a component of Nuedexta) carries a risk of serotonin syndrome when combined with serotonergic drugs.

Option 3: SNRIs — Off-Label

Serotonin-norepinephrine reuptake inhibitors (SNRIs) like venlafaxine (Effexor) are sometimes used off-label for PBA. While the evidence base for SNRIs in PBA is smaller than for SSRIs or TCAs, they may be a reasonable option for patients who need additional norepinephrine effects or who have comorbid pain conditions.

How Do Alternatives Compare to Nuedexta?

Nuedexta is the only medication with FDA approval and large randomized controlled trial data specifically for PBA. TCAs and SSRIs have smaller, older clinical studies for PBA and are not FDA-approved for this indication. However, for patients who cannot access Nuedexta, they can provide meaningful symptom relief under physician supervision.

Cost is a significant factor. Generic SSRIs and TCAs typically cost $10–$30 per month, compared to Nuedexta's retail price of over $1,500 per month without savings programs.

What Should I Do Before Switching to an Alternative?

Before switching medications, make sure you have tried all available resources to get Nuedexta. The manufacturer's co-pay card can bring your out-of-pocket cost to as little as $20 for a 30-day supply (for commercially insured patients), and the Otsuka Patient Assistance Foundation offers free medication for eligible uninsured patients.

If availability is the issue, review our guide on how to find Nuedexta in stock near you before making the switch.

The Bottom Line

Nuedexta is the gold standard for PBA treatment, but off-label options — especially SSRIs and TCAs — have a track record in clinical practice. Talk to your neurologist or prescriber about the best path forward for your specific situation. And if you still want to locate Nuedexta, medfinder can search pharmacies near you on your behalf.